RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,791 | +16.7% | 209 | -16.1% | 0.00% | – |
| Q2 2023 | $4,105 | +10.1% | 249 | +19.1% | 0.00% | – |
| Q1 2023 | $3,729 | -37.8% | 209 | 0.0% | 0.00% | – |
| Q4 2022 | $6,000 | +20.0% | 209 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +400.0% | 209 | -0.5% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 210 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -81.8% | 210 | -74.1% | 0.00% | – |
| Q3 2021 | $11,000 | -38.9% | 810 | -11.5% | 0.00% | – |
| Q2 2021 | $18,000 | -14.3% | 915 | -8.0% | 0.00% | – |
| Q1 2021 | $21,000 | -25.0% | 995 | +4.7% | 0.00% | – |
| Q4 2020 | $28,000 | +47.4% | 950 | +8.6% | 0.00% | – |
| Q3 2020 | $19,000 | +375.0% | 875 | +337.5% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |